Get Exclusive Perks!
Can Ketamine Shake Its Bad Rap?
Ketamine has a history as a date rape drug. As it becomes a therapy for depression, can it shake its bad rap?
Get Exclusive BODYCHEK Perks!
Psychedelic Business News Spotlight: January 22, 2021
This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and funds.
Canada Moves Closer Toward Legalizing Psychedelics
Canada is stepping toward legalization of psychedelics to aid in treating mental health issues.
Interview With Josh Bartch, Mydecine Innovations Group
Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founder & CEO, of Mydecine Innovations Group, Josh Bartch.
How Psychedelics Helped Shape Modern Technology
Psychedelics played a crucial role in technology as we know it, and they're playing a part in how it develops into the future, too.
Are Psychedelics the Secret for Coma Patients? Why This Doctor Thinks They Might Be
Should coma patients be given psychedelics? Dr. Hyder Khoja thinks they could be the best weapon in helping comatose people wake.
Interview With Henri Sant-Cassia, The Conscious Fund
Global Trac Solutions, Inc. CEO, David Flores sits down to speak with Co-Founding Partner at The Conscious Fund, Henri Sant-Cassia.
Follow Us on Instagram
Get a Roundup of Psychedelic News Stories in Your Inbox.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
Latest News
Is America Ready for Psilocybin Mushroom Retreats?
With Oregon's recent victory for psychedelics, psilocybin retreats could soon be commonplace. What does that mean for mental health treatment?
Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic Research
Wesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue its psychedelic research for traumatic brain injuries.
California Moves to Legalize Psychedelics
California may move to decriminalize psychedelics following the victories in Oregon and Washington D.C. last November.
Professor Michiel van Elk Awarded More Than $970,000 Grant to Study Psychedelics
Professor Michiel van Elk of the University of Leiden has been awarded a nearly $1 million to study psychedelics.
New Synthetic Ibogaine Treats Addiction With Fewer Side Effects
A new version of synthetic ibogaine can treat opioid addiction but with a decreased risk of cardiac arrhythmias.
Get a Roundup of Psychedelic News Stories in Your Inbox.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
